Used primarily as a key intermediate in pharmaceutical synthesis, especially in cross-coupling reactions such as Suzuki-Miyaura coupling. Its boronate ester group enables efficient formation of carbon-carbon bonds, making it valuable in the development of active pharmaceutical ingredients (APIs) for drugs targeting central nervous system disorders and inflammatory conditions. The presence of chlorine and trifluoromethyl groups allows for further functionalization, enhancing molecular diversity in drug discovery. It is also employed in the preparation of agrochemicals and functional materials where fluorinated heterocyclic structures are required.